Back to top
more

Moderna (MRNA)

(Delayed Data from NSDQ)

$154.27 USD

154.27
24,046,172

+13.93 (9.93%)

Updated Sep 1, 2026 03:59 PM ET

After-Market: $151.70 -2.57 (-1.67%) 5:44 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value A Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 36% (158 out of 248)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Stock Market News for Nov 20, 2020

by Zacks Equity Research

U.S. stock markets closed higher on Thursday on hopes of restarting of Congressional negotiations for a fresh tranche of fiscal stimulus.

Zacks Equity Research

EOG Resources (EOG) Up 32.8% MTD: What's Behind the Rally?

by Zacks Equity Research

Improving oil prices on positive coronavirus vaccine results aid EOG Resources (EOG).

Zacks Equity Research

5 Top Stocks to Buy Amid Potential Economic Recovery

by Zacks Equity Research

With the U.S. economy showing steady signs of a recovery and promising vaccine trials, it will be prudent to invest in fundamentally sound stocks like Crocs (CROX) and FedEx (FDX).

Sweta Killa headshot

Small Caps at the Forefront of Market Rally: 5 ETF Winners

by Sweta Killa

While the rally has been broad-based across all the market caps, small-caps stocks, as indicated by the Russell 2000 Index, has been outperforming and is hitting new all-time highs.

Zacks Equity Research

Pfizer/BioNTech COVID-19 Vaccine Shows Final Efficacy of 95%

by Zacks Equity Research

Pfizer (PFE) and BioNTech's (BNTX) COVID-19 vaccine candidate proves to be 95% effective in final analysis.

Ritujay Ghosh headshot

What Awaits Pharma Giants in Last Lap of COVID-19 Vaccine Race?

by Ritujay Ghosh

Pfizer, Inc. (PFE), BioNTech SE (BNTX), Eli Lilly and Company (LLY), AstraZeneca plc (AZN), Moderna, Inc. (MRNA) and Gilead Sciences, Inc. (GILD) are leading the race to come up with a vaccine for coronavirus.

Nilanjan Choudhury headshot

U.S. Crude Hits its Highest Price in 2 Months: Here's Why

by Nilanjan Choudhury

Some of the top gainers of the S&P 500 during the past month include energy-related names like Devon Energy (DVN), Baker Hughes Company (BKR), Diamondback Energy (FANG) and Marathon Oil (MRO).

Kevin Cook headshot

Bull Market to Surge on Vaccine Snapback

by Kevin Cook

How 5% GDP and 25% EPS growth could fuel a run to S&P 4,500 in 2021.

Zacks Equity Research

Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS

by Zacks Equity Research

Pipeline and regulatory updates take centerstage in the biotech sector as Moderna (MRNA) and Bristol Myers (BMY) among others provide updates.

Sweta Killa headshot

Bet on Quality ETFs as Vaccine Hope & Coronavirus Cases Rise

by Sweta Killa

Quality ETFs could enjoy smooth trading and generate market-beating returns in the current market environment.